Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Nevro Corp (NVRO)

Nevro Corp (NVRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Why Nevro Stock Lagged the Market on Thursday Motley Fool - Thu Feb 22, 5:21PM CST

Despite convincing beats on its latest set of quarterly figures, the market wasn't all that impressed with the company's latest developments.

NVRO : 11.29 (+1.26%)
Nevro: Q4 Earnings Snapshot AP - Wed Feb 21, 3:21PM CST

Nevro: Q4 Earnings Snapshot

NVRO : 11.29 (+1.26%)
Nevro: Q3 Earnings Snapshot AP - Wed Nov 1, 2023

Nevro: Q3 Earnings Snapshot

NVRO : 11.29 (+1.26%)
Nevro to Report Third Quarter 2023 Financial Results PR Newswire - Wed Oct 4, 2023

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 11.29 (+1.26%)
New Data Demonstrate the Health Economic Benefits of Nevro's High-Frequency Spinal Cord Stimulation Therapy PR Newswire - Mon Sep 18, 2023

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 11.29 (+1.26%)
Nevro Announces Participation in Upcoming Investor Conferences PR Newswire - Wed Aug 23, 2023

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain,...

NVRO : 11.29 (+1.26%)
New 24-Month Data Shows Nevro's SCS Therapy Provides Highly Effective, Long-Term Relief from Painful Diabetic Neuropathy PR Newswire - Wed Aug 16, 2023

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain,...

NVRO : 11.29 (+1.26%)
Why Shares of Nevro Are Down Wednesday Motley Fool - Wed Aug 2, 2023

The medical device maker saw increased revenue, but earnings lagged estimates.

NVRO : 11.29 (+1.26%)
Nevro: Q2 Earnings Snapshot AP - Tue Aug 1, 2023

Nevro: Q2 Earnings Snapshot

NVRO : 11.29 (+1.26%)
Nevro Reports Second Quarter 2023 Financial Results, Provides Third Quarter Guidance and Updates Full-Year 2023 Guidance PR Newswire - Tue Aug 1, 2023

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

NVRO : 11.29 (+1.26%)

Barchart Exclusives

How to Invest in Quality Stocks Right Now Barchart - 43 minutes ago
These 3 ETFs are worth considering for investors who are looking to add quality stocks to their portfolios, without spending the time and research on stock picking. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot